Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Toru Michi"'
Autor:
Yusuke Matsuzaka, Koichi Taniho, Kengo Maeda, Shintaro Sakai, Toru Michitsuji, Eriko Ozono, Yoshiro Morimoto, Hirohisa Kinoshita, Kayoko Matsushima, Hisayuki Hamada, Akira Imamura, Hirokazu Kumazaki, Hiroki Ozawa
Publikováno v:
BMC Medical Education, Vol 22, Iss 1, Pp 1-5 (2022)
Abstract Background Psychiatry rotation has been mandatory in the Japanese postgraduate residency system since 2020. Some psychiatry-related competency items are stipulated as mandatory for residents. The current study aimed to clarify whether psychi
Externí odkaz:
https://doaj.org/article/d3c6ce28b8a543e4aa0408c32475ea61
Autor:
Kaoru Kobayashi, Omi Terasaki, Takeshi Sassa, Kazutoshi Suzuki, Yasuhiko Sudo, Yasuhiro Someya, Yukio Tateno, Yoshiro Okubo, Toru Michi, Eisuke Matsushima, Tetsuya Suhara, Masaomi Iyo, Osamu Inoue
Publikováno v:
Life Sciences. 66:2455-2464
Using positron emission tomography (PET) and [11C]N-methylspiperone (NMSP), we examined 5-HT2 receptors in the cortex of schizophrenic patients in whom we previously observed decereased prefrontal D1 receptor binding. The subjects were 10 neuroleptic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c0e8130fc72336718f9abe94a3428db2
https://doi.org/10.1016/s0024-3205(00)80005-3
https://doi.org/10.1016/s0024-3205(00)80005-3
Autor:
Naoki Iwamoto, Shuntaro Sato, Shota Kurushima, Toru Michitsuji, Shinya Nishihata, Momoko Okamoto, Yoshika Tsuji, Yushiro Endo, Toshimasa Shimizu, Remi Sumiyoshi, Takahisa Suzuki, Akitomo Okada, Tomohiro Koga, Shin-ya Kawashiri, Keita Fujikawa, Takashi Igawa, Toshiyuki Aramaki, Kunihiro Ichinose, Mami Tamai, Hideki Nakamura, Akinari Mizokami, Tomoki Origuchi, Yukitaka Ueki, Katsumi Eguchi, Atsushi Kawakami
Publikováno v:
Arthritis Research & Therapy, Vol 23, Iss 1, Pp 1-10 (2021)
Abstract Objective To compare the efficacy and safety of tofacitinib and baricitinib in patients with RA in a real-world setting. Methods A total of 242 patients with RA who were treated with tofacitinib (n = 161) or baricitinib (n = 81) were enrolle
Externí odkaz:
https://doaj.org/article/1c8e820079284bae987b8836e8da78f7